Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1989-11

AUTHORS

Thomas Reissmann, Peter Hilgard, Rainer Voegeli, Jens Zeller

ABSTRACT

The present studies showed that nude mice xenotransplanted with L5222 leukemia responded as did syngeneic BD IX rats to low doses of mafosfamide or cyclophosphamide. Unlike rats, nude mice rarely showed resistance to a second tumor challenge. The observation that concurrent treatment of rats with cyclosporin A did not alter the rate of survival clearly indicated a T-cell-independent mechanism of tumor defense. The incidence of lung colonies from i.v. injected Lewis lung-tumor cells could be enhanced by a high dose pretreatment with mafosfamide or cyclophosphamide, whereas pretreatment at low doses was inhibitory. Since identical experiments carried out in NK-cell-deficient C57Bl/6 "beige" mice did not show such an effect, NK cells appeared to represent a possible effector cell in oxazaphosphorine-mediated antitumor effects. This assumption was further supported by the fact that enhanced NK cell activity could be observed in the 51Cr release assay using spleen cells from mafosfamide-treated L5222-bearing rats. The transplantation of the unrelated syngeneic ovarian carcinoma OV-342 to animals that had previously been cured of L5222 leukemia did not lead to the rejection of this tumor. This indicates that a specific resistance against L5222 leukemia had developed. In contrast, a T-cell-dependent antitumor effect was demonstrated for mafosfamide in the MOPC-315 mouse plasmocytoma. Therefore, we conclude that the effector cell for tumor rejection depends on the type of tumor. This, of course, does not exclude a common target cell for the immunopharmacological activity of oxazaphosphorines. More... »

PAGES

525-530

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00391352

DOI

http://dx.doi.org/10.1007/bf00391352

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1001265313

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2606928


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytotoxicity, Immunologic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Killer Cells, Natural", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Leukemia, Experimental", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, Nude", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ovarian Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasmacytoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Cells, Cultured", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reissmann", 
        "givenName": "Thomas", 
        "id": "sg:person.01340535776.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hilgard", 
        "givenName": "Peter", 
        "id": "sg:person.01023655171.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Voegeli", 
        "givenName": "Rainer", 
        "id": "sg:person.0633453775.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute for Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum, D-6900, Heidelberg, Federal Republic of Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zeller", 
        "givenName": "Jens", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01631649", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000151847", 
          "https://doi.org/10.1007/bf01631649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910150408", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002471216"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004798902"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(85)90016-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009463786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(85)90016-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009463786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.155.1.276", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012689937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/278451a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013138905", 
          "https://doi.org/10.1038/278451a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00204986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025873521", 
          "https://doi.org/10.1007/bf00204986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00204986", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025873521", 
          "https://doi.org/10.1007/bf00204986"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(86)90098-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026508026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0192-0561(86)90098-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026508026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1084/jem.161.5.1249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031090006"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035713745", 
          "https://doi.org/10.1007/bf00205439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205439", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035713745", 
          "https://doi.org/10.1007/bf00205439"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00047471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046220680", 
          "https://doi.org/10.1007/bf00047471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00047471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046220680", 
          "https://doi.org/10.1007/bf00047471"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052450309", 
          "https://doi.org/10.1007/bf00205559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00205559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052450309", 
          "https://doi.org/10.1007/bf00205559"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/262077a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053098476", 
          "https://doi.org/10.1038/262077a0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.7025208", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062643291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079645222", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079661323", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079719452", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079745935", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/78.4.735", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079768676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079909305", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1080029033", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1081632263", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082079384", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082165067", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082270364", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-11", 
    "datePublishedReg": "1989-11-01", 
    "description": "The present studies showed that nude mice xenotransplanted with L5222 leukemia responded as did syngeneic BD IX rats to low doses of mafosfamide or cyclophosphamide. Unlike rats, nude mice rarely showed resistance to a second tumor challenge. The observation that concurrent treatment of rats with cyclosporin A did not alter the rate of survival clearly indicated a T-cell-independent mechanism of tumor defense. The incidence of lung colonies from i.v. injected Lewis lung-tumor cells could be enhanced by a high dose pretreatment with mafosfamide or cyclophosphamide, whereas pretreatment at low doses was inhibitory. Since identical experiments carried out in NK-cell-deficient C57Bl/6 \"beige\" mice did not show such an effect, NK cells appeared to represent a possible effector cell in oxazaphosphorine-mediated antitumor effects. This assumption was further supported by the fact that enhanced NK cell activity could be observed in the 51Cr release assay using spleen cells from mafosfamide-treated L5222-bearing rats. The transplantation of the unrelated syngeneic ovarian carcinoma OV-342 to animals that had previously been cured of L5222 leukemia did not lead to the rejection of this tumor. This indicates that a specific resistance against L5222 leukemia had developed. In contrast, a T-cell-dependent antitumor effect was demonstrated for mafosfamide in the MOPC-315 mouse plasmocytoma. Therefore, we conclude that the effector cell for tumor rejection depends on the type of tumor. This, of course, does not exclude a common target cell for the immunopharmacological activity of oxazaphosphorines.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/bf00391352", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1313647", 
        "issn": [
          "0171-5216", 
          "1432-1335"
        ], 
        "name": "Journal of Cancer Research and Clinical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "115"
      }
    ], 
    "name": "Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression", 
    "pagination": "525-530", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "0606c90f1eab6102a69eadaa320ae571091630d59c0e780247e7f5c5b488fa80"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2606928"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7902060"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00391352"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1001265313"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00391352", 
      "https://app.dimensions.ai/details/publication/pub.1001265313"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130814_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/BF00391352"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00391352'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      21 PREDICATES      70 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00391352 schema:about N00e8a9c4754e4ecca2fd8a5e11e97732
2 N1118abb687594aec91051dbb5db57e0e
3 N15f008778e994931803d019b3c82e9cc
4 N1e7ba568ccb647be848b231108c908da
5 N2d08acd3b0c742a2b9c4ba6dad2ab87a
6 N30acac7a60da48eeaede245365cd5b60
7 N3a0b04b442754fc9b40f81bc839816c8
8 N3fa03bbeb2704f18b11dd7cdc8a08d04
9 N5447db3569604688a0a34b6ba262d14c
10 N7d3e7f8ee2a9403eb7465395bf383659
11 Na62ce4d164394486aa642be8137dbd44
12 Naf339f58d07744dcbef8c0f1e2fea09f
13 Nb37b7a9a0d9444e5ab2825d1dee310c0
14 Nc733813fdb1840f0a4a64d1ca6eaad0b
15 Nd72837f7a13b4a7ca0b6f677e182506d
16 Nee7f6428a7804e48add6d47c9e0cb4d0
17 anzsrc-for:11
18 anzsrc-for:1107
19 schema:author Ndf9d208b19634cc1a61a00dec3fa0d19
20 schema:citation sg:pub.10.1007/bf00047471
21 sg:pub.10.1007/bf00204986
22 sg:pub.10.1007/bf00205439
23 sg:pub.10.1007/bf00205559
24 sg:pub.10.1007/bf01631649
25 sg:pub.10.1038/262077a0
26 sg:pub.10.1038/278451a0
27 https://app.dimensions.ai/details/publication/pub.1079645222
28 https://app.dimensions.ai/details/publication/pub.1079661323
29 https://app.dimensions.ai/details/publication/pub.1079719452
30 https://app.dimensions.ai/details/publication/pub.1079745935
31 https://app.dimensions.ai/details/publication/pub.1079909305
32 https://app.dimensions.ai/details/publication/pub.1080029033
33 https://app.dimensions.ai/details/publication/pub.1081632263
34 https://app.dimensions.ai/details/publication/pub.1082079384
35 https://app.dimensions.ai/details/publication/pub.1082165067
36 https://app.dimensions.ai/details/publication/pub.1082270364
37 https://doi.org/10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h
38 https://doi.org/10.1002/ijc.2910150408
39 https://doi.org/10.1016/0192-0561(85)90016-5
40 https://doi.org/10.1016/0192-0561(86)90098-6
41 https://doi.org/10.1084/jem.155.1.276
42 https://doi.org/10.1084/jem.161.5.1249
43 https://doi.org/10.1093/jnci/78.4.735
44 https://doi.org/10.1126/science.7025208
45 schema:datePublished 1989-11
46 schema:datePublishedReg 1989-11-01
47 schema:description The present studies showed that nude mice xenotransplanted with L5222 leukemia responded as did syngeneic BD IX rats to low doses of mafosfamide or cyclophosphamide. Unlike rats, nude mice rarely showed resistance to a second tumor challenge. The observation that concurrent treatment of rats with cyclosporin A did not alter the rate of survival clearly indicated a T-cell-independent mechanism of tumor defense. The incidence of lung colonies from i.v. injected Lewis lung-tumor cells could be enhanced by a high dose pretreatment with mafosfamide or cyclophosphamide, whereas pretreatment at low doses was inhibitory. Since identical experiments carried out in NK-cell-deficient C57Bl/6 "beige" mice did not show such an effect, NK cells appeared to represent a possible effector cell in oxazaphosphorine-mediated antitumor effects. This assumption was further supported by the fact that enhanced NK cell activity could be observed in the 51Cr release assay using spleen cells from mafosfamide-treated L5222-bearing rats. The transplantation of the unrelated syngeneic ovarian carcinoma OV-342 to animals that had previously been cured of L5222 leukemia did not lead to the rejection of this tumor. This indicates that a specific resistance against L5222 leukemia had developed. In contrast, a T-cell-dependent antitumor effect was demonstrated for mafosfamide in the MOPC-315 mouse plasmocytoma. Therefore, we conclude that the effector cell for tumor rejection depends on the type of tumor. This, of course, does not exclude a common target cell for the immunopharmacological activity of oxazaphosphorines.
48 schema:genre research_article
49 schema:inLanguage en
50 schema:isAccessibleForFree false
51 schema:isPartOf N198a52d3abe14a16847a84433a8664a2
52 Ne69743d506d04933b495f5f4334898cf
53 sg:journal.1313647
54 schema:name Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression
55 schema:pagination 525-530
56 schema:productId N02a90cf1fdcf4be89b0961170dcdcf9a
57 N5a166179c4dd415e86311224463a4190
58 N887760b6793d4e2e8fe44056b69c8207
59 N8f678427f2b440079dfa26d63346968e
60 Nb91938528c58448c8b5b2775b2d77a22
61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001265313
62 https://doi.org/10.1007/bf00391352
63 schema:sdDatePublished 2019-04-11T13:55
64 schema:sdLicense https://scigraph.springernature.com/explorer/license/
65 schema:sdPublisher Nf47d5a1b3d4e4d6da444fdbc46bfaefe
66 schema:url http://link.springer.com/10.1007/BF00391352
67 sgo:license sg:explorer/license/
68 sgo:sdDataset articles
69 rdf:type schema:ScholarlyArticle
70 N00e8a9c4754e4ecca2fd8a5e11e97732 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Mice
72 rdf:type schema:DefinedTerm
73 N02a90cf1fdcf4be89b0961170dcdcf9a schema:name readcube_id
74 schema:value 0606c90f1eab6102a69eadaa320ae571091630d59c0e780247e7f5c5b488fa80
75 rdf:type schema:PropertyValue
76 N1118abb687594aec91051dbb5db57e0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
77 schema:name Animals
78 rdf:type schema:DefinedTerm
79 N15f008778e994931803d019b3c82e9cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Rats
81 rdf:type schema:DefinedTerm
82 N18ec1e038ae44c678d80943dc826ec1c rdf:first N9bb66429eea74402903722034e750b72
83 rdf:rest rdf:nil
84 N198a52d3abe14a16847a84433a8664a2 schema:issueNumber 6
85 rdf:type schema:PublicationIssue
86 N1e7ba568ccb647be848b231108c908da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Mice, Nude
88 rdf:type schema:DefinedTerm
89 N2d08acd3b0c742a2b9c4ba6dad2ab87a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Plasmacytoma
91 rdf:type schema:DefinedTerm
92 N30acac7a60da48eeaede245365cd5b60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Mice, Inbred Strains
94 rdf:type schema:DefinedTerm
95 N330e20ab0406403a9f6035b392bf81f5 schema:name Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany
96 rdf:type schema:Organization
97 N3a0b04b442754fc9b40f81bc839816c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Ovarian Neoplasms
99 rdf:type schema:DefinedTerm
100 N3fa03bbeb2704f18b11dd7cdc8a08d04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Tumor Cells, Cultured
102 rdf:type schema:DefinedTerm
103 N5447db3569604688a0a34b6ba262d14c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Killer Cells, Natural
105 rdf:type schema:DefinedTerm
106 N551cd0bb93474aadb9ac5a2bd93dbbc5 rdf:first sg:person.01023655171.21
107 rdf:rest Nd8861d52baf14f4981af56f54e8de3c4
108 N5a166179c4dd415e86311224463a4190 schema:name pubmed_id
109 schema:value 2606928
110 rdf:type schema:PropertyValue
111 N7d3e7f8ee2a9403eb7465395bf383659 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Cyclosporins
113 rdf:type schema:DefinedTerm
114 N887760b6793d4e2e8fe44056b69c8207 schema:name doi
115 schema:value 10.1007/bf00391352
116 rdf:type schema:PropertyValue
117 N8f678427f2b440079dfa26d63346968e schema:name dimensions_id
118 schema:value pub.1001265313
119 rdf:type schema:PropertyValue
120 N9bb66429eea74402903722034e750b72 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
121 schema:familyName Zeller
122 schema:givenName Jens
123 rdf:type schema:Person
124 Na62ce4d164394486aa642be8137dbd44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 Naf339f58d07744dcbef8c0f1e2fea09f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Cyclophosphamide
129 rdf:type schema:DefinedTerm
130 Nb37b7a9a0d9444e5ab2825d1dee310c0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Leukemia, Experimental
132 rdf:type schema:DefinedTerm
133 Nb91938528c58448c8b5b2775b2d77a22 schema:name nlm_unique_id
134 schema:value 7902060
135 rdf:type schema:PropertyValue
136 Nc733813fdb1840f0a4a64d1ca6eaad0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Female
138 rdf:type schema:DefinedTerm
139 Ncdb5a9741abd468a9ab49d81001faefa schema:name Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany
140 rdf:type schema:Organization
141 Nd72837f7a13b4a7ca0b6f677e182506d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Cytotoxicity, Immunologic
143 rdf:type schema:DefinedTerm
144 Nd8861d52baf14f4981af56f54e8de3c4 rdf:first sg:person.0633453775.54
145 rdf:rest N18ec1e038ae44c678d80943dc826ec1c
146 Ndf9d208b19634cc1a61a00dec3fa0d19 rdf:first sg:person.01340535776.53
147 rdf:rest N551cd0bb93474aadb9ac5a2bd93dbbc5
148 Ne3b6529f36024f4fa93243718f983b4d schema:name Department of Experimental Cancer Research, ASTA Pharma AG, D-4800, Bielefeld 14, Federal Republic of Germany
149 rdf:type schema:Organization
150 Ne69743d506d04933b495f5f4334898cf schema:volumeNumber 115
151 rdf:type schema:PublicationVolume
152 Nee7f6428a7804e48add6d47c9e0cb4d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Neoplasm Transplantation
154 rdf:type schema:DefinedTerm
155 Nf47d5a1b3d4e4d6da444fdbc46bfaefe schema:name Springer Nature - SN SciGraph project
156 rdf:type schema:Organization
157 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
158 schema:name Medical and Health Sciences
159 rdf:type schema:DefinedTerm
160 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
161 schema:name Immunology
162 rdf:type schema:DefinedTerm
163 sg:journal.1313647 schema:issn 0171-5216
164 1432-1335
165 schema:name Journal of Cancer Research and Clinical Oncology
166 rdf:type schema:Periodical
167 sg:person.01023655171.21 schema:affiliation Ne3b6529f36024f4fa93243718f983b4d
168 schema:familyName Hilgard
169 schema:givenName Peter
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023655171.21
171 rdf:type schema:Person
172 sg:person.01340535776.53 schema:affiliation Ncdb5a9741abd468a9ab49d81001faefa
173 schema:familyName Reissmann
174 schema:givenName Thomas
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340535776.53
176 rdf:type schema:Person
177 sg:person.0633453775.54 schema:affiliation N330e20ab0406403a9f6035b392bf81f5
178 schema:familyName Voegeli
179 schema:givenName Rainer
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633453775.54
181 rdf:type schema:Person
182 sg:pub.10.1007/bf00047471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046220680
183 https://doi.org/10.1007/bf00047471
184 rdf:type schema:CreativeWork
185 sg:pub.10.1007/bf00204986 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025873521
186 https://doi.org/10.1007/bf00204986
187 rdf:type schema:CreativeWork
188 sg:pub.10.1007/bf00205439 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035713745
189 https://doi.org/10.1007/bf00205439
190 rdf:type schema:CreativeWork
191 sg:pub.10.1007/bf00205559 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052450309
192 https://doi.org/10.1007/bf00205559
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/bf01631649 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000151847
195 https://doi.org/10.1007/bf01631649
196 rdf:type schema:CreativeWork
197 sg:pub.10.1038/262077a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053098476
198 https://doi.org/10.1038/262077a0
199 rdf:type schema:CreativeWork
200 sg:pub.10.1038/278451a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013138905
201 https://doi.org/10.1038/278451a0
202 rdf:type schema:CreativeWork
203 https://app.dimensions.ai/details/publication/pub.1079645222 schema:CreativeWork
204 https://app.dimensions.ai/details/publication/pub.1079661323 schema:CreativeWork
205 https://app.dimensions.ai/details/publication/pub.1079719452 schema:CreativeWork
206 https://app.dimensions.ai/details/publication/pub.1079745935 schema:CreativeWork
207 https://app.dimensions.ai/details/publication/pub.1079909305 schema:CreativeWork
208 https://app.dimensions.ai/details/publication/pub.1080029033 schema:CreativeWork
209 https://app.dimensions.ai/details/publication/pub.1081632263 schema:CreativeWork
210 https://app.dimensions.ai/details/publication/pub.1082079384 schema:CreativeWork
211 https://app.dimensions.ai/details/publication/pub.1082165067 schema:CreativeWork
212 https://app.dimensions.ai/details/publication/pub.1082270364 schema:CreativeWork
213 https://doi.org/10.1002/1097-0142(19860615)57:12<2309::aid-cncr2820571212>3.0.co;2-h schema:sameAs https://app.dimensions.ai/details/publication/pub.1004798902
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1002/ijc.2910150408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002471216
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1016/0192-0561(85)90016-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009463786
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1016/0192-0561(86)90098-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026508026
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1084/jem.155.1.276 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012689937
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1084/jem.161.5.1249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031090006
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1093/jnci/78.4.735 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079768676
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1126/science.7025208 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062643291
228 rdf:type schema:CreativeWork
229 https://www.grid.ac/institutes/grid.7497.d schema:alternateName German Cancer Research Center
230 schema:name Institute for Toxicology and Chemotherapy, Deutsches Krebsforschungszentrum, D-6900, Heidelberg, Federal Republic of Germany
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...